AC Immune SA (NASDAQ: ACIU) reported Q3 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $940 thousand versus the consensus estimate of $311.72 thousand.

For earnings history and earnings-related data on AC Immune SA (ACIU) click here.